Catalyst Wire Dossier Catalyst Wire Dossier

APD334

· Arena Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APD334, covering 2021-06-11 to 2021-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum [Phase 2]

See pricing